- World rank, 2022–2025
- #10,578 of 28,054 · #18,732 all time
- Rank in China
- #1,907 of 3,058
- Research works
- 1.1k ▼ 57% vs 2013–17
- Citations
- 4.2k 3.9 per fractional work
- Top-10% rate
- 21.7% record average 16.5%
- Open access
- 21% world 28%
What is Gaozhou People's Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,107 of 10,443 | 21.1% | 97 | #8233 | |
| Health SciencesDomain | #5,586 of 11,982 | 20.7% | 100 | #10602 |
Each strip is that field’s whole ranked pool, with the notch where Gaozhou People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.3×
- Medicine 3.2×
- Immunology and Microbiology 3.1×
- Veterinary 1.5×
- Neuroscience 1.4×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Nursing 1.2×
- Materials Science 1.0×
- Dentistry 0.7×
- Health Professions 0.4×
- Decision Sciences 0.4×
- Engineering 0.3×
- Computer Science 0.3×
- Agricultural and Biological Sciences 0.3×
- Physics and Astronomy 0.2×
- Chemistry 0.2×
- Psychology 0.2×
- Environmental Science 0.1×
- Energy 0.1×
- Mathematics 0.0×
- Earth and Planetary Sciences 0.0×
- Social Sciences 0.0×
Which keywords describe research at Gaozhou People's Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Epidemiology, Gene Expression, Tumor Microenvironment, Chemotherapy, Biomarkers and Radiotherapy.
- Cancer Biomarkers
- Long Noncoding RNAs
- Tumor Targeting
- Esophageal Carcinoma
- Echocardiography
- Surgery
- Ferroptosis
- Chemoradiation
- Clinical Trials
- Global Burden
- Neoadjuvant Therapy
- Precision Medicine
- Cell Death
- Biogenesis
- Management
- Immunotherapy
- Biomarkers
- Tumor Microenvironment
- Oxidative Stress
- Epidemiology
- Cancer
- Inflammation
- Gene Expression
- Chemotherapy
- Cardiovascular Disease
- Diagnosis
- Radiotherapy
- Regulation
- Metastasis
- Epigenetic Regulation
- Clinical Practice Guidelines
- Prognostic Factors
- Meta-Analysis
- Drug Delivery
- Lipid Peroxidation
- Endoscopic Resection
- Barrett's Esophagus
- Preoperative Chemoradiotherapy
- Disease
- RNA Regulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer18▲ 8.6×38 topics
- Epidemiology15▲ 2.4×57 topics
- Inflammation14▲ 4.2×57 topics
- Oxidative Stress8▲ 3.2×32 topics
- Gene Expression8▲ 8.5×9 topics
- Tumor Microenvironment8▲ 11×8 topics
- Chemotherapy7▲ 6.2×15 topics
- Biomarkers6▲ 6.0×12 topics
- Cardiovascular Disease6▲ 3.5×20 topics
- Immunotherapy6▲ 5.4×14 topics
- Diagnosis6▲ 4.0×16 topics
- Management6▲ 4.7×15 topics
- Radiotherapy6▲ 9.1×9 topics
- Biogenesis6▲ 20×3 topics
- Regulation5▲ 6.1×7 topics
- Cell Death5▲ 13×5 topics
- Metastasis5▲ 8.9×10 topics
- Precision Medicine4▲ 5.6×4 topics
- Epigenetic Regulation4▲ 12×5 topics
- Neoadjuvant Therapy4▲ 11×5 topics
- Clinical Practice Guidelines4▲ 4.5×14 topics
- Global Burden4▲ 4.6×8 topics
- Prognostic Factors4▲ 5.6×11 topics
- Clinical Trials4▲ 3.6×11 topics
- Meta-Analysis4▲ 4.1×6 topics
- Chemoradiation4▲ 36×2 topics
- Drug Delivery4▲ 4.2×8 topics
- Ferroptosis4▲ 30×1 topic
- Lipid Peroxidation4▲ 22×1 topic
- Surgery4▲ 6.5×6 topics
- Endoscopic Resection4▲ 22×2 topics
- Echocardiography3▲ 7.9×6 topics
- Barrett's Esophagus3▲ 48×1 topic
- Esophageal Carcinoma3▲ 48×1 topic
- Preoperative Chemoradiotherapy3▲ 25×2 topics
- Tumor Targeting3▲ 11×2 topics
- Disease3▲ 20×2 topics
- Long Noncoding RNAs3▲ 21×1 topic
- RNA Regulation3▲ 17×1 topic
- Cancer Biomarkers3▲ 20×3 topics
Which research topics does Gaozhou People's Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Esophageal Cancer Research and Treatment, Cancer-related molecular mechanisms research and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 4 works
- 2 Esophageal Cancer Research and Treatment Surgery 3 works
- 3 Cancer-related molecular mechanisms research Cancer Research 3 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 6 Circular RNAs in diseases Molecular Biology 2 works
- 7 MicroRNA in disease regulation Cancer Research 2 works
- 8 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 9 Nanoplatforms for cancer theranostics Biomedical Engineering 2 works
- 10 Esophageal and GI Pathology Surgery 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Gaozhou People's Hospital's research output changed?
Output in 2018–2022 was 57% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.